Amherst, NH, United States of America

Stephen Blinn

This inventor holds 1 USPTO granted patent and 3 EPO patents. Top assignee: Avedro, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stephen Blinn. Retrieved from https://idiyas.com/inventor/stephen-blinn

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Stephen Blinn

Introduction

Stephen Blinn is an accomplished inventor based in Amherst, NH (US). He is currently associated with Avedro, Inc., a company known for its advancements in the field of ophthalmology. Despite having no patents to his name, his contributions to the industry are noteworthy.

Latest Patents

As of now, Stephen Blinn holds 1 patents. However, his work at Avedro, Inc. continues to influence the development of innovative solutions in eye care.

Career Highlights

Throughout his career, Stephen has been involved in various projects that aim to enhance patient outcomes in ophthalmic treatments. His role at Avedro, Inc. has allowed him to collaborate with leading experts in the field.

Collaborations

Stephen has worked alongside talented individuals such as David Muller and Marc David Friedman. Their combined expertise fosters a creative environment that drives innovation at Avedro, Inc.

Conclusion

In summary, Stephen Blinn is a dedicated inventor whose work at Avedro, Inc. contributes significantly to the field of ophthalmology. His collaborations and commitment to innovation highlight his importance in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…